Analyze Diet

Topic:Pharmaceuticals

Pharmaceuticals in equine medicine encompass a wide range of drugs and therapeutic agents used to treat various conditions in horses. These substances include analgesics, anti-inflammatories, antibiotics, sedatives, and anthelmintics, among others. Each class of pharmaceuticals is designed to address specific health issues, such as pain management, infection control, or parasitic infestations. The pharmacokinetics and pharmacodynamics of these drugs can vary significantly between horses and other species, necessitating careful consideration of dosage and administration methods. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, safety, and regulatory aspects of pharmaceuticals used in equine healthcare.
GC-MS characterization of urinary metabolites and changes of ethisterone and testosterone profile after oral administration of danazol in equine.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 2 147-153 doi: 10.1046/j.1365-2885.2001.00317.x
Kim JY, Choi MH, Kim SJ, Kyong JB, Chung BC.No abstract available
Pharmacokinetic disposition and faecal excretion of pyrantel embonate following oral administration in horses.
Journal of veterinary pharmacology and therapeutics    May 12, 2001   Volume 24, Issue 1 77-79 doi: 10.1046/j.1365-2885.2001.00305.x
Gokbulut C, Nolan AM, McKellar QA.No abstract available
The metabolism of norethandrolone in the horse: characterization of 16-, 20- and 21-oxygenated metabolites by gas chromatography/mass spectrometry.
Journal of mass spectrometry : JMS    April 5, 2001   Volume 36, Issue 2 145-150 doi: 10.1002/jms.111
McKinney AR, Ridley DD, Suann CJ.After oral administration to a thoroughbred gelding, the anabolic steroid norethandrolone was converted into a complex mixture of oxygenated metabolites. These metabolites were extracted from the urine, deconjugated by methanolysis and converted to their O-methyloxime trimethylsilyl derivatives. Gas chromatographic/mass spectrometric analysis indicated the major metabolites to be 19-norpregnane-3,16,17-triols, 19-norpregnane-3,17,20-triols and 3,17-dihydroxy-19-norpregnan-21-oic acids. Some minor metabolites were also detected.
The use of psychoactive agents in veterinary medicine.
International journal of pharmaceutical compounding    March 1, 2001   Volume 5, Issue 2 86-88 
Simpson BS.Psychotropic drugs are used by veterinary behavior specialists and general veterinary practitioners to treat behavior problems of companion animals. Dogs, cats, pet birds, horses, and zoo animals benefit from this type of therapy. However, many drugs used to treat anxiety or depression in animals were designed for use in human patients. Compounding is a critical step in adapting those medications for use in different species. Formulations that improve palatability or facilitate administration can often determine the success or failure of therapy in veterinary patients, and compounding is often...
Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants.
American journal of veterinary research    February 24, 2001   Volume 62, Issue 1 54-60 doi: 10.2460/ajvr.2001.62.54
Moses VS, Hardy J, Bertone AL, Weisbrode SE.To evaluate the effects of anti-inflammatory drugs on lipopolysaccharide (LPS)-challenged and -unchallenged equine synovial membrane in terms of production of prostaglandin E2 (PGE2) and hyaluronan, viability, and histomorphologic characteristics. Methods: Synovial membranes were collected from the carpal, tarsocrural, and femoropatellar joints of 6 adult horses. Methods: Synovial membranes from each horse were minced and pooled and explants were treated with one of the following: no drug (control), drug, LPS alone, or LPS and drug. Treatment drugs were phenylbutazone (PBZ), flunixin meglumine...
Pharmacokinetics of propranolol and its metabolites in horses after intravenous or oral administration.
Biological & pharmaceutical bulletin    November 21, 2000   Volume 23, Issue 11 1333-1340 doi: 10.1248/bpb.23.1333
Aramaki S, Mori M, Nakata M, Shinohara A, Koizumi T.The pharmacokinetics characteristics of propranolol (PPL) in horses was studied by administering the drug intravenously or orally to the animals. The predominant primary pathway was ring oxidation, and 4-hydroxypropranolol glucuronide (4-OHPG) was the major metabolite in both plasma and urine. Side-chain glucuronidation and oxidation were not significant. A two-compartment model was employed for PPL followed by a one-compartment model for 4-OHPG. After oral administration, one-step absorption and two-step first pass metabolism were employed. The fraction absorbed of PPL was approximately 70% a...
Quantification of phenytoin and its metabolites in equine plasma and urine using high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications    November 15, 2000   Volume 746, Issue 2 209-218 doi: 10.1016/s0378-4347(00)00330-3
Guan F, Uboh CE, Soma LR, Birks EK, Teleis D, Rudy JA, Watson AO, Tsang DS.A reliable and sensitive method for the extraction and quantification of phenytoin (5,5'-diphenylhydantoin), its major metabolite, 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) and minor metabolite, 5-(m-hydroxyphenyl)-5-phenylhydantoin (m-HPPH) in horse urine and plasma is described. The method involves the use of solid-phase extraction (SPE), liquid-liquid extraction (LLE), enzyme hydrolysis (EH) and high-performance liquid chromatography (HPLC). The minor metabolite, 5-(m-hydroxyphenyl)-5-phenylhydantoin (m-HPPH) was not present in a reliably quantifiable concentration in all samples. The ...
Ingestion of equine moxidectin by dogs.
The Veterinary record    November 1, 2000   Volume 147, Issue 12 339-340 
Brown D.No abstract available
Identification of hydroxyropivacaine glucuronide in equine urine by ESI+/MS/MS.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire    August 10, 2000   Volume 64, Issue 3 178-183 
Harkins JD, Karpiesiuk W, Tobin T, Dirikolu L, Lehner AF.Ropivacaine is a local anesthetic that has a high potential for abuse in racing horses. It can be recovered from urine collected after administration as a hydroxylated metabolite following beta-glucuronidase treatment of the urine. Based on these findings, it has been inferred that ropivacaine is present in equine urine as a glucuronide metabolite; however, these metabolites have never been directly identified. Using ESI+/MS/MS, the presence of a [M+H]+ molecular ion of m/z 467 was demonstrated in urine corresponding to the calculated mass of a hydroxyropivacaine glucuronide +1. The abundance ...
Remifentanil in the horse: identification and detection of its major urinary metabolite.
Journal of analytical toxicology    August 5, 2000   Volume 24, Issue 5 309-315 doi: 10.1093/jat/24.5.309
Lehner AF, Almeida P, Jacobs J, Harkins JD, Karpiesiuk W, Woods WE, Dirikolu L, Bosken JM, Carter WG, Boyles J, Holtz C, Heller T, Nattrass C....Remifentanil (4-methoxycarbonyl-4-[(1-oxopropyl)phenylamino]-1-piperidinepropionic acid methyl ester) is a mu-opioid receptor agonist with considerable abuse potential in racing horses. The identification of its major equine urinary metabolite, 4-methoxycarbonyl-4-[(1-oxopropyl)phenylamino]-1-piperidinepropionic+ ++ acid, an ester hydrolysis product of remifentanil is reported. Administration of remifentanil HCl (5 mg, intravenous) produced clear-cut locomotor responses, establishing the clinical efficacy of this dose. ELISA analysis of postadministration urine samples readily detected fentany...
[Veterinary drug profile of Equest].
Tijdschrift voor diergeneeskunde    July 25, 2000   Volume 125, Issue 8 258-261 
van Turnhout J, Boersema J, Pellicaan C.No abstract available
Retail sale of equine medicines.
The Veterinary record    July 20, 2000   Volume 146, Issue 25 739 
Greet T, Jones R.No abstract available
Questions duration of treatment with phenylbutazone.
American journal of veterinary research    July 15, 2000   Volume 61, Issue 7 728 doi: 10.2460/ajvr.2000.61.728
Reilly FK.No abstract available
Histidin as a mercurial poisoning inhibitor.
Biochemical and biophysical research communications    July 13, 2000   Volume 273, Issue 3 816-819 doi: 10.1006/bbrc.2000.3021
Myshkin AE, Khromova VS.Histidin has been shown to effectively inhibit coagulation of horse oxyhemoglobin (HbO(2)) modified by mercury(II) ion bound to reactive thiol groups of protein. Kinetic parameters were measured and the histidin-to-mercury binding constant was kinetically estimated. Histidin, as other pharmaceutically acceptable compounds with some mercury-binding capacity, has been suggested to alleviate mercury intoxication conditions.
Evaluation of samarium-153 for synovectomy in an osteochondral fragment-induced model of synovitis in horses.
Veterinary surgery : VS    June 28, 2000   Volume 29, Issue 3 252-263 doi: 10.1053/jvet.2000.5611
Yarbrough TB, Lee MR, Hornof WJ, Schumacher HR, O'Brien TR.To determine the effects of intraarticular administration of Samarium-153 (153Sm) bound to hydroxyapatite microspheres (153SmM) on an osteochondral chip-induced synovitis. Methods: Sixty days after implantation of autogenous osteochondral fragments in the middle carpal and metacarpophalangeal joints, 153SmM was administered into 1 joint of each type. The contralateral joints were used as untreated controls. Methods: Fifteen horses without preexisting joint disease were randomly divided into 2 groups (7 in the carpal group, 8 in the metacarpophalangeal group). Methods: Horses had osteochondral ...
Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses.
Journal of veterinary pharmacology and therapeutics    June 10, 2000   Volume 23, Issue 2 107-110 doi: 10.1046/j.1365-2885.2000.00249.x
Dowling PM, Russell AM.No abstract available
Pharmacokinetics of fleroxacin in horses.
Journal of veterinary pharmacology and therapeutics    June 10, 2000   Volume 23, Issue 2 103-105 doi: 10.1046/j.1365-2885.2000.00248.x
Rebuelto M, Otero P, Albarellos G, Ambros L, Kreil V, Waxman S, Montoya L, Hallu R.No abstract available
Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications    April 25, 2000   Volume 738, Issue 1 17-25 doi: 10.1016/s0378-4347(99)00478-8
Grippa E, Santini L, Castellano G, Gatto MT, Leone MG, Saso L.Ethyl acetate extracts of equine serum, containing 0-5 microg/ml of hydrocortisone (HYD), dexamethasone (DEX), oxyphenbutazone (OPB), indomethacin (IND), phenylbutazone (PB) and probenecid as internal standard, were evaporated with nitrogen, resuspended in methanol and analyzed by HPLC, using a C-18 column equilibrated with 51:49 acetonitrile-water, 0.1% trifluoroacetic acid, at 1 ml/min. The eluate was monitored at 254 nm. The selectivity (inter-assay C.V.<4%), sensitivity (limits of quantitation of 0.25 microg/ml for HYD, DEX and IND, 0.5 microg/ml for PB and 1 microg/ml for OPB, despite ...
Equine metabolism of buspirone studied by high-performance liquid chromatography/mass spectrometry.
Journal of mass spectrometry : JMS    April 18, 2000   Volume 35, Issue 3 402-407 doi: 10.1002/(SICI)1096-9888(200003)35:33.0.CO;2-L
Stanley SM.The metabolism and urinary excretion of a 100 mg dose of the non-sedating anxiolytic drug buspirone was examined using high-performance liquid chromatography/electrospray ionization mass spectrometry in the positive ion mode. In addition to a significant proportion of unchanged buspirone we were able to detect three major metabolite classes. These were identified as monohydroxy, dihydroxy and dihydroxymethoxy products. Detection of the metabolites and the parent drug was possible in all the urine samples collected (1-12 h) post-administration.
Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
Veterinary therapeutics : research in applied veterinary medicine    April 1, 2000   Volume 1, Issue 2 125-132 
Furr M, Kennedy T.Toltrazuril 5% suspension (Baycox, Bayer Canada, Ontario, Canada) was administered to six adult horses followed by blood collection and assay to determine the concentration of toltrazuril and its principal metabolites, toltrazuril sulfone and toltrazuril sulfoxide. From this data, the maximum concentration (C(max)), elimination half-life (T 1/2), and mean residence times of the plasma were determined from standard pharmacokinetic formulas. After a single oral dose of 10 mg/kg body weight a rapid absorption was found, with a mean peak serum concentration of 11.17 mg/L at 18 hours. Elimination w...
Isoxsuprine: more questions than answers.
Equine veterinary journal    April 1, 2000   Volume 32, Issue 2 90-91 doi: 10.2746/042516400777591507
Elliott J.No abstract available
Use of 99mTc-mercaptoacetyltriglycine to evaluate renal function in horses. Woods PR, Drost WT, Clarke CR, Rodebush CJ.Ten healthy horses were injected intravenously with 99mTc-MAG3 and the disappearance of radioactivity from the blood was measured. The total body clearance (Cl(B)) and elimination half-life (t1/2(beta)) were 7.9 +/- 1.5 ml/kg/minute and 32.8 +/- 4.1 minutes, respectively. The disappearance of 99mTc-MAG3 from the blood of 2 horses with compromised renal function was also measured. The data suggest that 99mTc-MAG3 is a useful and clinically applicable radiopharmaceutical for measurement of effective renal blood flow in the horse.
Availability of equine medicines.
The Veterinary record    February 8, 2000   Volume 146, Issue 1 27-28 
Jones R, Greet T.No abstract available
Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics.
Journal of veterinary pharmacology and therapeutics    January 29, 2000   Volume 22, Issue 6 374-379 doi: 10.1046/j.1365-2885.1999.00232.x
Dirikolu L, Lehner F, Nattrass C, Bentz BG, Woods WE, Carter WG, Karpiesiuk W, Jacobs J, Boyles J, Harkins JD, Granstrom DE, Tobin T.Diclazuril (4-chlorophenyl [2,6-dichloro-4-(4,5-dihydro-3H-3,5-dioxo-1,2,4-triazin-2-yl)pheny l] acetonitrile), is a benzeneacetonitrile antiprotozoal agent (Janssen Research Compound R 64433) marketed as Clinacox . Diclazuril may have clinical application in the treatment of Equine Protozoal Myeloencephalitis (EPM). To evaluate its bioavailability and preliminary pharmacokinetics in the horse we developed a sensitive quantitative high-pressure liquid chromatography (HPLC) method for diclazuril in equine biological fluids. MS/MS analysis of diclazuril in our HPLC solvent yielded mass spectral ...
Tolerability of orally administered enrofloxacin in adult horses: a pilot study.
Journal of veterinary pharmacology and therapeutics    December 22, 1999   Volume 22, Issue 5 343-347 doi: 10.1046/j.1365-2885.1999.00224.x
Giguère S, Sweeney RW, Habecker PL, Lucas J, Richardson DW.No abstract available
Equine reproductive pharmacology.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 687-x doi: 10.1016/s0749-0739(17)30139-6
Perkins NR.This article reviews therapies and strategies commonly used to treat diseases of the mare's genital tract and modulate the reproductive cycle of the mare. Many reproductive treatments are based on historical use and empirical evidence rather than well controlled clinical studies. This article attempts to present practical information in a summary form while highlighting the need for continued research documenting the efficacy and safety of reproductive therapies.
Formulary of common equine drugs.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 747-xi doi: 10.1016/s0749-0739(17)30142-6
Whittem T.This article presents in easily accessible form a collection of drug names and dose rates for the drugs recommended or referred to by the authors of the individual articles in this issue. Although the formulary provides recommendations for drug use, the reader is cautioned that the responsibility for the choice of agent, formulation, dose, and dose interval lies with the clinician. The author also addresses regulations that govern the use of drugs in competition horses.
Therapeutics of musculoskeletal disease in the horse.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 589-602 doi: 10.1016/s0749-0739(17)30134-7
Kollias-Baker C.Therapeutic medications play a crucial role in the successful therapy of many musculoskeletal diseases that occur in horses. For example, appropriate antibiotic therapy is extremely important in the treatment of diseases caused by infections with microorganisms such as botulism, tetanus, osteomyelitis, and muscle abscesses. In addition, numerous prescription medications and nutritional supplements are available for the treatment of osteoarthritis in horses. Many of these agents currently on the market fall into a new class of drugs called SADMO agents. Unfortunately, the efficacy and mechanism...
Pharmacokinetic interactions between flunixin and sulphadimidine in horses.
DTW. Deutsche tierarztliche Wochenschrift    November 5, 1999   Volume 106, Issue 9 400-403 
el-Banna HA.The pharmacokinetic aspects of sulphadimidine were studied in clinically healthy (control) and Flunixin-medicated horses after a single intravenous and oral administration of 100 mg/kg body weight. Plasma sulphadimidine concentration were determined by high-performance liquid chromatography (HPLC). Following the intravenous injection, all plasma sulphadimidine data were best approximated by a two-compartment open model using sequential, weight non-linear regression. Flunixin induced a 67% increase in the rate of sulphadimidine return to the central compartment from peripheral tissues (K21) and...
Use of unlicensed medicines.
The Veterinary record    October 26, 1999   Volume 145, Issue 12 352 
Keith NW.No abstract available
1 17 18 19 20 21 37